Biofrontera (BFRI)
Provides AMELUZ and RhodoLED photodynamic therapy for dermatology practices.
$1.57
Pre-market+0.06 (+3.63%)
At close$1.52(−1.30%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions12 holders · as of Mar 31, 2026 | 18.68% | 2.39M shares | |
| Insiders7 holders · as of Jul 29, 2026 | 20.45% | 2.62M shares | |
| Strategic holders1 holder · as of Jul 9, 2025 | 3.12% | 400.0K shares | |
| Otherremainder | 57.75% | 7.39M shares |
12.80M company shares as of Aug 24, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (14.85M in the company's Sep 3, 2026 report, 12.80M elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
12 holders · 2.39M shares · 2 new positions · 9 increased · 1 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 1.16M | 9.09% | +23.2K | May 14, 2026 |
| Aigh Capital Management LLC | 915.2K | 7.15% | 0 | Apr 30, 2026 |
| Geode Capital Management, LLC | 109.3K | 0.85% | +43.6K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 61.7K | 0.48% | +61.7Knew | May 8, 2026 |
| Vanguard Capital Management LLC | 52.3K | 0.41% | +52.3Knew | May 15, 2026 |
| Susquehanna International Group, LLP | 38.6K | 0.30% | +27.0K | May 15, 2026 |
| XTX Topco Ltd | 22.5K | 0.18% | +3.6K | May 15, 2026 |
| Citigroup Inc | 11.8K | 0.09% | +11.8K | May 11, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Deutsche Balaton Aktiengesellschaftincl. Biofrontera AG, Maria del Pilar de la Huerta Martinez +5 more | 19.99% | 2.55M | 13D | Sep 19, 2025 ↗ |
| Rosalind Advisors, Inc. | 9.90% | 13G | Feb 11, 2026 ↗ | |
| Orin Hirschman | 7.90% | 915.2K | 13G | Jan 28, 2026 ↗ |
| Nabil Saad | 6.09% | 337.8K | 13G | Sep 12, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 16, 2025 | Biofrontera AGdirector, 10 percent owner: | Purchase | 3,019 | $0.0006 | 3,019 |
CongressHouse and Senate disclosures
Not reported.
